封面
市場調查報告書
商品編碼
1747141

日本心血管設備市場規模、佔有率、趨勢及預測(按設備類型、應用、最終用戶和地區),2025 年至 2033 年

Japan Cardiovascular Devices Market Size, Share, Trends and Forecast by Device Type, Application, End User, and Region, 2025-2033

出版日期: | 出版商: IMARC | 英文 121 Pages | 商品交期: 5-7個工作天內

價格
簡介目錄

2024年,日本心血管設備市場規模達330萬美元。展望未來, IMARC Group預計到2033年,該市場規模將達到701萬美元,2025-2033年期間的複合年成長率(CAGR)為8.08%。人口老化、心血管疾病發生率上升以及技術進步是推動市場發展的因素。關鍵細分市場包括心律調節器、支架和監測設備。政府措施和不斷增加的醫療保健投資支撐著市場成長,而監管政策則影響產品的核准和應用。

日本心血管設備市場趨勢:

微創心血管手術需求不斷成長

由於人口老化和導管治療技術的進步,日本對微創 (MI) 心血管設備的需求日益成長。經導管主動脈瓣置換術 (TAVR) 和經皮冠狀動脈介入治療 (PCI) 的採用率正在上升,這減少了住院時間並加快了患者康復。日本醫療器材公司正在投資機器人輔助手術和下一代導管,以提高精準度。在日本藥品和醫療器材綜合機構 (PMDA) 的指導下,監管環境正在簡化突破性技術的核准,從而加快市場准入。此外,人工智慧 (AI) 正在提高心血管影像診斷的精準度,協助早期介入方案的發展。例如,2024 年 9 月,總部位於日本的 Cardio Intelligence 公司推出了 SmartRobin AI,這是一款由可解釋的人工智慧驅動的心電圖監測系統,可快速檢測心房顫動,從而提高中風風險評估和心血管護理診斷的準確性。此外,隨著政府對家庭醫療保健的支持,穿戴式心電圖儀和植入式循環記錄器等遠端監測設備也越來越受歡迎。這一趨勢符合日本「價值導向醫療」的理念,強調成本效益和病患治療效果。隨著報銷政策的轉變,市場可望預期微創心血管解決方案將迎來成長。

人工智慧整合心血管診斷的成長

人工智慧正在改變日本的心血管診斷,改善早期疾病檢測和預測分析。人工智慧驅動的超音波心動圖和電腦斷層掃描 (CT) 成像儀能夠更快、更準確地診斷心臟病。大型研究中心和醫院正在應用人工智慧即時監測心臟,減輕醫護人員的負擔。機器學習技術正被整合到電子健康記錄 (EHR) 中,用於預測心臟衰竭風險,從而實現預防性治療。日本對數位健康創新的關注正促使醫療科技公司與人工智慧新創公司展開合作,以加速智慧診斷設備的部署。政府對個人化醫療的推動也推動了人工智慧賦能的心血管護理,以便根據基因和生活方式因素制定精準的治療方案。隨著人工智慧減少診斷錯誤並提高工作流程效率,其在心血管設備中的應用正在不斷增加,從而改善了患者管理並節省了長期醫療成本。例如,2024 年 9 月,奧林巴斯在歐洲、亞洲和大洋洲推出了 VISERA S,這是一款具有 NBI 和頻閃功能的一體化成像平台,透過改進的可視化和簡化的工作流程增強了耳鼻喉診斷。

穿戴式和遠端心臟監測設備的擴展

隨著日本人口老化和心臟病發病率的上升,穿戴式和遠端心臟監測設備正在迅速普及。內建心電圖的智慧手錶、手持式動態心電圖監測儀和植入式心臟事件記錄器正成為預防心臟病學的基石。 5G 連接的出現正在加速即時資料傳輸,使醫生能夠遠端監測患者並在危急事件發生前發現異常。日本設備製造商正在研發小巧易用、電池續航力更長的穿戴設備,以提高患者依從性。隨著日本加快醫療數位化進程,日本藥品生產和醫療器材管理局 (PMDA) 的支持正在推動尖端遠距醫療解決方案的快速核准。保險公司開始為遠端監測服務提供報銷,進一步推動了市場擴張。隨著診所和醫院部署基於雲端的心臟監測系統,在日本不斷變化的心血管護理環境中,數據驅動的資訊正在最大限度地最佳化治療方案,降低再入院率,並改善患者預後。

日本心血管設備市場細分:

設備類型洞察:

  • 診斷和監測設備
    • 心電圖(ECG)
    • 遠端心臟監測
    • 其他
  • 治療及外科手術設備
    • 心律管理 (CRM) 設備
    • 導管
    • 支架
    • 心臟瓣膜
    • 其他

應用程式洞察:

  • 冠狀動脈疾病(CAD)
  • 心律不整
  • 心臟衰竭
  • 其他

最終用戶洞察:

  • 醫院
  • 專科診所
  • 其他

競爭格局:

市場研究報告也對競爭格局進行了全面的分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀錶板和公司評估象限等競爭分析。此外,報告還提供了所有主要公司的詳細資料。

本報告回答的關鍵問題:

  • 日本心血管設備市場迄今表現如何?未來幾年將如何表現?
  • 根據設備類型,日本心血管設備市場是如何分類的?
  • 日本心血管設備市場根據應用如何分類?
  • 根據最終用戶,日本心血管設備市場是如何分類的?
  • 日本心血管設備市場的價值鏈分為哪些階段?
  • 日本心血管設備的主要促進因素和挑戰是什麼?
  • 日本心血管設備市場的結構是怎麼樣的?主要參與者是誰?
  • 日本心血管設備市場的競爭程度如何?

本報告回答的關鍵問題:

  • 日本心血管設備市場迄今表現如何?未來幾年將如何表現?
  • 根據設備類型,日本心血管設備市場是如何分類的?
  • 日本心血管設備市場根據應用如何分類?
  • 根據最終用戶,日本心血管設備市場是如何分類的?
  • 日本心血管設備市場的價值鏈分為哪些階段?
  • 日本心血管設備的主要促進因素和挑戰是什麼?
  • 日本心血管設備市場的結構是怎麼樣的?主要參與者是誰?
  • 日本心血管設備市場的競爭程度如何?

目錄

第1章:前言

第2章:範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章:執行摘要

第4章:日本心血管設備市場-簡介

  • 概述
  • 市場動態
  • 產業趨勢
  • 競爭情報

第5章:日本心血管設備市場格局

  • 歷史與當前市場趨勢(2019-2024)
  • 市場預測(2025-2033)

第6章:日本心血管設備市場-細分:依設備類型

  • 診斷和監測設備
    • 概述
    • 市場區隔
      • 心電圖(ECG)
      • 遠端心臟監測
      • 其他
  • 治療及外科手術設備
    • 概述
    • 市場區隔
      • 心律管理 (CRM) 設備
      • 導管
      • 支架
      • 心臟瓣膜
      • 其他

第7章:日本心血管設備市場-細分:依應用

  • 冠狀動脈疾病(CAD)
    • 概述
  • 心律不整
    • 概述
  • 心臟衰竭
    • 概述
  • 其他

第 8 章:日本心血管設備市場 - 細分:按最終用戶

  • 醫院
    • 概述
  • 專科診所
    • 概述
  • 其他

第9章:日本心血管設備市場-競爭格局

  • 概述
  • 市場結構
  • 市場參與者定位
  • 最佳獲勝策略
  • 競爭儀錶板
  • 公司評估象限

第10章:關鍵參與者簡介

  • Company A
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company B
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company C
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company D
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company E
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events

第 11 章:日本心血管設備市場 - 產業分析

  • 促進因素、限制因素和機遇
    • 概述
    • 驅動程式
    • 限制
    • 機會
  • 波特五力分析
    • 概述
    • 買家的議價能力
    • 供應商的議價能力
    • 競爭程度
    • 新進入者的威脅
    • 替代品的威脅
  • 價值鏈分析

第 12 章:附錄

簡介目錄
Product Code: SR112025A32512

The Japan cardiovascular devices market size reached USD 3.30 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 7.01 Million by 2033, exhibiting a growth rate (CAGR) of 8.08% during 2025-2033. The market is driven by an aging population, rising cardiovascular diseases, and technological advancements. Key segments include pacemakers, stents, and monitoring devices. Government initiatives and increasing healthcare investments support market growth, while regulatory policies influence product approvals and adoption.

Japan Cardiovascular Devices Market Trends:

Rising Demand for Minimally Invasive Cardiovascular Procedures

Japan is facing a higher demand for minimally invasive (MI) cardiovascular devices owing to an aging population and improved catheter-based treatments. The adoption of transcatheter aortic valve replacement (TAVR) and percutaneous coronary interventions (PCI) is rising, reducing hospital stays and accelerating recovery. Japanese medical device companies are investing in robotics-assisted procedures and next-generation catheters to improve precision. The regulatory environment, under the guidance of the Pharmaceuticals and Medical Devices Agency (PMDA), is making approval easier for groundbreaking technologies, permitting quicker market entry. Furthermore, artificial intelligence (AI) is improving the precision of cardiovascular imaging diagnostics, aiding early intervention protocols. For example, in September 2024, Japan-based Cardio Intelligence introduced SmartRobin AI, an ECG monitoring system powered by explainable AI for fast atrial fibrillation detection, enhancing stroke risk assessment and diagnostic accuracy in cardiovascular care. Additionally, with home healthcare being supported by the government, remote monitoring devices such as wearable ECGs and implantable loop recorders are also becoming popular. The trend is in support of Japan's value-based medicine drive, stressing cost-effectiveness and patient outcome. With shifting reimbursement policies, the market can anticipate increased growth in minimally invasive cardiovascular solutions.

Growth of AI-Integrated Cardiovascular Diagnostics

AI is transforming cardiovascular diagnostics in Japan, improving early disease detection and predictive analytics. AI-driven echocardiography and computed tomography (CT) imaging machines are enabling faster, more accurate diagnosis of heart disease. Large research centers and hospitals are applying AI in real-time monitoring of the heart, reducing the burden on healthcare personnel. ML technologies are being integrated into electronic health records (EHRs) for predicting risks of heart failure, allowing preventive treatment modalities. The focus on digital health innovation in Japan is inducing collaborations between medtech firms and AI startups to accelerate the deployment of intelligent diagnostic equipment. The government drive in personalized medicine is also driving AI-enabled cardiovascular care so that precise treatment plans are delivered based on gene and lifestyle factors. As AI reduces diagnostic errors and increases workflow efficiency, its use in cardiovascular devices is increasing, leading to improved patient management and long-term healthcare cost savings. For instance, in September 2024, Olympus launched VISERA S, an all-in-one imaging platform with NBI and stroboscopy, across Europe, Asia, and Oceania, enhancing ENT diagnostics with improved visualization and streamlined workflow.

Expansion of Wearable and Remote Cardiac Monitoring Devices

Wearable and remote cardiac monitoring devices are gaining quick adoption in Japan, fueled by the increasing age population and the rising incidence of heart diseases. Smartwatches with built-in ECG, hand-carried Holter monitors, and implantable cardiac event recorders are becoming cornerstones of preventive cardiology. The emergence of 5G connectivity is accelerating real-time data transmission, allowing doctors to monitor patients remotely and catch anomalies before critical events. Japanese device makers are creating small, easy-to-use wearables with longer battery life to drive patient compliance. PMDA support is driving speedy approvals of cutting-edge telemedicine solutions as the nation accelerates healthcare digitalization. Insurers are starting to reimburse for remote monitoring services, further driving market expansion. As clinics and hospitals implement cloud-based cardiac monitoring systems, data-driven information is maximizing treatment plans, lowering hospital readmissions, and enhancing patient outcomes in Japan's changing cardiovascular care environment.

Japan Cardiovascular Devices Market Segmentation:

Device Type Insights:

  • Diagnostic and Monitoring Devices
    • Electrocardiogram (ECG)
    • Remote Cardiac Monitoring
    • Others
  • Therapeutic and Surgical Devices
    • Cardiac Rhythm Management (CRM) Devices
    • Catheter
    • Stents
    • Heart Valves
    • Others

Application Insights:

  • Coronary Artery Disease (CAD)
  • Cardiac Arrhythmia
  • Heart Failure
  • Others

End User Insights:

  • Hospitals
  • Specialty Clinics
  • Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan cardiovascular devices market performed so far and how will it perform in the coming years?
  • What is the breakup of the Japan cardiovascular devices market on the basis of device type?
  • What is the breakup of the Japan cardiovascular devices market on the basis of application?
  • What is the breakup of the Japan cardiovascular devices market on the basis of end user?
  • What are the various stages in the value chain of the Japan cardiovascular devices market?
  • What are the key driving factors and challenges in the Japan cardiovascular devices?
  • What is the structure of the Japan cardiovascular devices market and who are the key players?
  • What is the degree of competition in the Japan cardiovascular devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Cardiovascular Devices Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Cardiovascular Devices Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan Cardiovascular Devices Market - Breakup by Device Type

  • 6.1 Diagnostic and Monitoring Devices
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Segmentation
      • 6.1.3.1 Electrocardiogram (ECG)
      • 6.1.3.2 Remote Cardiac Monitoring
      • 6.1.3.3 Others
    • 6.1.4 Market Forecast (2025-2033)
  • 6.2 Therapeutic and Surgical Devices
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Segmentation
      • 6.2.3.1 Cardiac Rhythm Management (CRM) Devices
      • 6.2.3.2 Catheter
      • 6.2.3.3 Stents
      • 6.2.3.4 Heart Valves
      • 6.2.3.5 Others
    • 6.2.4 Market Forecast (2025-2033)

7 Japan Cardiovascular Devices Market - Breakup by Application

  • 7.1 Coronary Artery Disease (CAD)
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Forecast (2025-2033)
  • 7.2 Cardiac Arrhythmia
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Forecast (2025-2033)
  • 7.3 Heart Failure
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2019-2024)
    • 7.3.3 Market Forecast (2025-2033)
  • 7.4 Others
    • 7.4.1 Historical and Current Market Trends (2019-2024)
    • 7.4.2 Market Forecast (2025-2033)

8 Japan Cardiovascular Devices Market - Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2019-2024)
    • 8.1.3 Market Forecast (2025-2033)
  • 8.2 Specialty Clinics
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2019-2024)
    • 8.2.3 Market Forecast (2025-2033)
  • 8.3 Others
    • 8.3.1 Historical and Current Market Trends (2019-2024)
    • 8.3.2 Market Forecast (2025-2033)

9 Japan Cardiovascular Devices Market - Competitive Landscape

  • 9.1 Overview
  • 9.2 Market Structure
  • 9.3 Market Player Positioning
  • 9.4 Top Winning Strategies
  • 9.5 Competitive Dashboard
  • 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

  • 10.1 Company A
    • 10.1.1 Business Overview
    • 10.1.2 Services Offered
    • 10.1.3 Business Strategies
    • 10.1.4 SWOT Analysis
    • 10.1.5 Major News and Events
  • 10.2 Company B
    • 10.2.1 Business Overview
    • 10.2.2 Services Offered
    • 10.2.3 Business Strategies
    • 10.2.4 SWOT Analysis
    • 10.2.5 Major News and Events
  • 10.3 Company C
    • 10.3.1 Business Overview
    • 10.3.2 Services Offered
    • 10.3.3 Business Strategies
    • 10.3.4 SWOT Analysis
    • 10.3.5 Major News and Events
  • 10.4 Company D
    • 10.4.1 Business Overview
    • 10.4.2 Services Offered
    • 10.4.3 Business Strategies
    • 10.4.4 SWOT Analysis
    • 10.4.5 Major News and Events
  • 10.5 Company E
    • 10.5.1 Business Overview
    • 10.5.2 Services Offered
    • 10.5.3 Business Strategies
    • 10.5.4 SWOT Analysis
    • 10.5.5 Major News and Events

11 Japan Cardiovascular Devices Market - Industry Analysis

  • 11.1 Drivers, Restraints, and Opportunities
    • 11.1.1 Overview
    • 11.1.2 Drivers
    • 11.1.3 Restraints
    • 11.1.4 Opportunities
  • 11.2 Porters Five Forces Analysis
    • 11.2.1 Overview
    • 11.2.2 Bargaining Power of Buyers
    • 11.2.3 Bargaining Power of Suppliers
    • 11.2.4 Degree of Competition
    • 11.2.5 Threat of New Entrants
    • 11.2.6 Threat of Substitutes
  • 11.3 Value Chain Analysis

12 Appendix